- Home
- SAGE vs API Comparison
SAGE vs API Comparison
Compare SAGE & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- API
- Stock Information
- Founded
- SAGE 2010
- API 2013
- Country
- SAGE United States
- API United States
- Employees
- SAGE N/A
- API N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- API Computer Software: Prepackaged Software
- Sector
- SAGE Health Care
- API Technology
- Exchange
- SAGE Nasdaq
- API Nasdaq
- Market Cap
- SAGE 474.6M
- API 518.0M
- IPO Year
- SAGE 2014
- API 2020
- Fundamental
- Price
- SAGE $7.77
- API $4.03
- Analyst Decision
- SAGE Hold
- API Strong Buy
- Analyst Count
- SAGE 19
- API 1
- Target Price
- SAGE $9.88
- API $6.00
- AVG Volume (30 Days)
- SAGE 1.2M
- API 585.5K
- Earning Date
- SAGE 04-24-2025
- API 05-21-2025
- Dividend Yield
- SAGE N/A
- API N/A
- EPS Growth
- SAGE N/A
- API N/A
- EPS
- SAGE N/A
- API N/A
- Revenue
- SAGE $41,243,000.00
- API $133,256,000.00
- Revenue This Year
- SAGE $100.39
- API $6.89
- Revenue Next Year
- SAGE $70.86
- API $10.96
- P/E Ratio
- SAGE N/A
- API N/A
- Revenue Growth
- SAGE N/A
- API N/A
- 52 Week Low
- SAGE $4.62
- API $1.65
- 52 Week High
- SAGE $17.51
- API $6.99
- Technical
- Relative Strength Index (RSI)
- SAGE 48.49
- API 33.20
- Support Level
- SAGE $7.99
- API $3.82
- Resistance Level
- SAGE $8.81
- API $4.84
- Average True Range (ATR)
- SAGE 0.31
- API 0.28
- MACD
- SAGE -0.06
- API -0.11
- Stochastic Oscillator
- SAGE 9.57
- API 11.11
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.